BBP ETF
Virtus LifeSci Biotech Products ETF
BBP ETF Overview
BBP ETF (Virtus LifeSci Biotech Products ETF) is managed by Virtus Investment Partners with $132.8M in net assets. BBP expense ratio is 0.34%, holding 138 positions across sectors including Health Care. Inception date: 2014-12-16.
BBP performance shows a YTD return of 33.16%. The 1-year return is 57.52% and the 5-year return is 15.07%.
BBP top holdings include Moderna therapeutics (3.8%), Iovance Biotherapeutics Inc (2.9%), Omeros Corp Com (2.6%), Verastem Inc (2.4%), Halozyme Therapeutics Inc (2.0%). Go to all BBP holdings, BBP sectors, or BBP dividends.
BBP can be compared against other funds. Use BBP overlap to find shared positions, or BBP vs another fund for a side-by-side view. BBP alternatives are available via the screener, along with tax-loss harvesting opportunities.